Piramal Pharma Share Price
24 Aug, 2026 3:54 PM (IST)
Piramal Pharma Performance
- Today's Low
- ₹210
- Today's High
- ₹215
- 52 Week Low
- ₹132
- 52 Week High
- ₹220
- Open Price₹214
- Previous Close₹214
- Volume2,810,899
- 50 DMA₹191.60
- 100 DMA₹181.60
- 200 DMA₹178.90
Piramal Pharma Chart
Investment Returns
- Over 1 Month + 16.77%
- Over 3 Month + 20.22%
- Over 6 Month + 30.23%
- Over 1 Year + 9.55%
Smart Investing Starts Here Start SIP with Piramal Pharma for Steady Growth!
Piramal Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -89.6
- PEG Ratio
- 0.2
- Market Cap Cr
- 28,111
- P/B Ratio
- 3.5
- Average True Range
- 7.6
- EPS
- -2.4
- Dividend Yield
- 0
- MACD Signal
- 7.7
- RSI
- 61.68
- MFI
- 73.04
Latest Stock News Updates
Please refer attached file
- BSE India
- 6 hours 49 minutes ago
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
- Business Line
- 5 days 16 hours ago
Please find enclosed intimation of acquisition of additional stake in Yapan Bio Private Limited
- BSE India
- 6 days 12 hours ago
Piramal Pharma Financials
Piramal Pharma Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹204.90
- 50 Day
- ₹191.60
- 100 Day
- ₹181.60
- 200 Day
- ₹178.90
Resistance and Support
- R3 219.10
- R2 217.00
- R1 214.10
- S1 209.00
- S2 206.90
- S3 204.00
Piramal Pharma Corporate Actions - Bonus, Splits, Dividends
About Piramal Pharma
Piramal Pharma is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network. We operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (“CDMO”) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (“APIs”), Finished dosage forms (“FDFs”), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (“CHG“) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and Piramal Consumer Healthcare (“PCH“) business, selling well-known OTC brands. View More- NSE Symbol
- PPLPHARMA
- BSE Symbol
- 543635
- ISIN
- INE0DK501011
Similar Stocks to Piramal Pharma
Popular Stocks
Piramal Pharma FAQs
Piramal Pharma share price is ₹211 As on 24 August, 2026 | 23:36
The Market Cap of Piramal Pharma is ₹28111.4 Cr As on 24 August, 2026 | 23:36
The P/E ratio of Piramal Pharma is -89.6 As on 24 August, 2026 | 23:36
The PB ratio of Piramal Pharma is 3.5 As on 24 August, 2026 | 23:36
The 52 week High & Low of Piramal Pharma is ₹220.4/₹132.3 respectively As on 24 August, 2026 | 23:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.